These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9196534)

  • 1. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis.
    Hoekstra MO; van Aalderen WM
    Thorax; 1997 Apr; 52(4):398-9. PubMed ID: 9196534
    [No Abstract]   [Full Text] [Related]  

  • 2. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.
    Mukhopadhyay S; Singh M; Cater JI; Ogston S; Franklin M; Olver RE
    Thorax; 1996 Apr; 51(4):364-8. PubMed ID: 8733486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Making antibiotic therapy easier to use. A welcome advance for those with cystic fibrosis].
    Sabourin G
    Perspect Infirm; 2011; 8(4):54-5. PubMed ID: 21812190
    [No Abstract]   [Full Text] [Related]  

  • 4. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
    Châtain P
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF; Mouton J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract]   [Full Text] [Related]  

  • 6. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis.
    McNamara PS; McCormack P; McDonald AJ; Heaf L; Southern KW
    J Cyst Fibros; 2009 Jul; 8(4):258-63. PubMed ID: 19447080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment of cystic fibrosis.
    Jedlicková Z; Vávrová V; Houstĕk J; Výmola F
    Acta Univ Carol Med (Praha); 1990; 36(1-4):42-3. PubMed ID: 2130716
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
    Kernen Y; Sauty A; Roulet M
    Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulised antipseudomonal therapy in cystic fibrosis.
    Touw DJ; Bakker W
    Thorax; 1996 Dec; 51(12):1283. PubMed ID: 8994535
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudomonas eradication in cystic fibrosis: who will join the ELITE?
    Smyth AR
    Thorax; 2010 Apr; 65(4):281-2. PubMed ID: 20388748
    [No Abstract]   [Full Text] [Related]  

  • 11. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D; Desmazes-Dufeu N; Dusser D
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract]   [Full Text] [Related]  

  • 12. Once daily dosing of aminoglycosides.
    Matthews Z; Cistulli K; Barnes D
    Aust N Z J Med; 1994 Dec; 24(6):730; author reply 731. PubMed ID: 7717931
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
    Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
    Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems of antibiotic therapy in mucoviscidosis].
    Steinitz H
    Z Allgemeinmed; 1972 Aug; 48(24):1085-9. PubMed ID: 4649651
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cystic fibrosis: current therapy. Antibiotics].
    Tamm M; Héritier F; Rappaz I; Schaad UB
    Schweiz Med Wochenschr Suppl; 2000; 122():33S-37S. PubMed ID: 12536469
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
    Saiman L
    Paediatr Respir Rev; 2007 Sep; 8(3):249-55. PubMed ID: 17868923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosfomycin--investigation of a possible new route of administration of an old drug. A case study.
    Cree M; Stacey S; Graham N; Wainwright C
    J Cyst Fibros; 2007 May; 6(3):244-6. PubMed ID: 17055346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of FEV1 changes related to antibiotic therapy in children with cystic fibrosis.
    Javadpour S; Jones A; Brownlee K
    Ir Med J; 2007; 100(7):529-32. PubMed ID: 17886526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
    Lahiri T
    Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A liposome model to treat pseudomonas in lungs of cystic fibrosis and immune compromised patients.
    Yatvin MB
    Cell Mol Biol Lett; 2002; 7(2):304. PubMed ID: 12097974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.